ACCOUNTS - Final Accounts preparation

ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2023.0.135 2023.0.135 2023-09-302023-09-302022-10-01true11falsefalseNo description of principal activityThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08209320 2022-10-01 2023-09-30 08209320 2021-10-01 2022-09-30 08209320 2023-09-30 08209320 2022-09-30 08209320 c:Director1 2022-10-01 2023-09-30 08209320 d:ComputerEquipment 2022-10-01 2023-09-30 08209320 d:ComputerEquipment 2023-09-30 08209320 d:ComputerEquipment 2022-09-30 08209320 d:ComputerEquipment d:OwnedOrFreeholdAssets 2022-10-01 2023-09-30 08209320 d:CurrentFinancialInstruments 2023-09-30 08209320 d:CurrentFinancialInstruments 2022-09-30 08209320 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 08209320 d:CurrentFinancialInstruments d:WithinOneYear 2022-09-30 08209320 d:ShareCapital 2023-09-30 08209320 d:ShareCapital 2022-09-30 08209320 d:RetainedEarningsAccumulatedLosses 2023-09-30 08209320 d:RetainedEarningsAccumulatedLosses 2022-09-30 08209320 c:FRS102 2022-10-01 2023-09-30 08209320 c:AuditExempt-NoAccountantsReport 2022-10-01 2023-09-30 08209320 c:FullAccounts 2022-10-01 2023-09-30 08209320 c:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 08209320 e:PoundSterling 2022-10-01 2023-09-30 iso4217:GBP xbrli:pure

Registered number: 08209320










MEDCONNECT LTD








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2023

 
MEDCONNECT LTD
REGISTERED NUMBER: 08209320

STATEMENT OF FINANCIAL POSITION
AS AT 30 SEPTEMBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
281
-

  
281
-

Current assets
  

Debtors: amounts falling due within one year
 5 
4,429
13,707

Cash at bank and in hand
  
60,930
26,084

  
65,359
39,791

Creditors: amounts falling due within one year
 6 
(46,865)
(19,049)

Net current assets
  
 
 
18,494
 
 
20,742

Total assets less current liabilities
  
18,775
20,742

  

Net assets
  
18,775
20,742


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
18,774
20,741

  
18,775
20,742


Page 1

 
MEDCONNECT LTD
REGISTERED NUMBER: 08209320
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 SEPTEMBER 2023

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Dr A Benjamin-Laing
Director

Date: 18 April 2024

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
MEDCONNECT LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

1.


General information

Medconnect Ltd is a private company limited by shares and incorporated in England and Wales, registration number 08209320. The registered office is 8 The Courtyards, Wyncolls Road, Severalls Industrial Park, Colchester, Essex, CO4 9PE.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Page 3

 
MEDCONNECT LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

2.Accounting policies (continued)

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of
financial assets and liabilities like trade and other debtors and creditors, loans from banks and other
third parties, loans to related parties and investments in ordinary shares.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 4

 
MEDCONNECT LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).


4.


Tangible fixed assets





Computer equipment

£



Cost or valuation


Additions
300



At 30 September 2023

300



Depreciation


Charge for the year on owned assets
19



At 30 September 2023

19



Net book value



At 30 September 2023
281



At 30 September 2022
-


5.


Debtors

2023
2022
£
£


Trade debtors
4,429
-

Other debtors
-
13,707

4,429
13,707


Page 5

 
MEDCONNECT LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Corporation tax
21,096
6,471

Other creditors
24,089
12,578

Accruals and deferred income
1,680
-

46,865
19,049


 
Page 6